Medicines and the New Economic Environment
(1998; 252 pages) [Spanish]
Índice de contenido
Ver el documentoTHE AUTHORS
Ver el documentoPREFACE
Ver el documentoINTRODUCTION
Abrir esta carpeta y ver su contenidoI. THE GLOBAL ECONOMIC ENVIRONMENT
Cerrar esta carpetaII. THE REFORM OF HEALTH CARE SYSTEMS
Cerrar esta carpetaII. 1. Cost Containment and Health care Reforms: the Impact on Pharmaceuticals
Ver el documento1. INTRODUCTION
Cerrar esta carpeta2. COST CONTAINMENT MEASURES
Ver el documento2.1. Cost-sharing
Ver el documento2.2. Expenditure ceilings
Ver el documento2.3. Limiting doctors and hospital beds
Ver el documento2.4. Alternatives to in-patient care
Ver el documento2.5. Influencing the resource use authorised by doctors
Ver el documento2.6. Pharmaceutical prices
Ver el documento2.7. A profit control system for Europe?
Ver el documento2.8. The effectiveness of cost containment measures: potential for further action
Abrir esta carpeta y ver su contenido3. LONG TERM SOLUTIONS
Ver el documento4. CONCLUSIONS
Ver el documentoREFERENCES
Abrir esta carpeta y ver su contenidoII.2. Reform of Health Care Services in Developing Countries, Role of the State and Essential Drugs
Abrir esta carpeta y ver su contenidoII.3. Regulation, Policies and Essential Drugs
Abrir esta carpeta y ver su contenidoIII. A CHANGING PHARMACEUTICAL INDUSTRY
Abrir esta carpeta y ver su contenidoIV. SYNTHESIS AND FORECASTS
Ver el documentoBIBLIOTECA CIVITAS ECONOMÍA Y EMPRESA
Ver el documentoBACK COVER
 
2.3. Limiting doctors and hospital beds

A common theme have been controls on entry to medical education (now exercised in all countries except Belgium and Luxembourg which has no medical school). Of more immediate effect are the controls to enter insurance practice. In most Member States new capital developments in the public sector (and in some cases in the private sector as well) have to be authorised by national, regional or local planning bodies. In Belgium, Ireland and the United Kingdom, there has been very extensive firm action to close hospitals or change them to other uses. There are now plans to close 22,000 public hospitals beds in France and 3,800 in the Netherlands. In Denmark, also the number of hospitals has been falling, mainly through the closure of small units: further reductions are expected. In Spain, smaller acute hospitals have been transferred to use by the chronic sick or by convalescent patients and some have been closed. It is recognised in Luxembourg, that there is a surplus of acute beds, but the procedures to change them for other uses are slow and cumbersome. By contrast, in Portugal and Greece, there is still a trend to build more public hospitals with a slight increase in acute beds.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013